Tuesday, 29 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14499
Articles
Company
Drug
R&B Biotech Receives FDA Approval for ZS805 Gene Therapy in Fabry Disease
June 3, 2025
Company
Drug
GSK’s Linerixibat NDA Accepted by FDA for Cholestatic Pruritus in PBC Patients
June 3, 2025
Company
Deals
Shanghai Ark Bio and Partex Collaborate on ATR Inhibitor AK0658 Development
June 3, 2025
Company
Drug
Bayer Files for Approval of Gadoquatrane MRI Contrast Agent in Japan
June 3, 2025
Company
Deals
MicroPort CardioFlow to Acquire 49% Stake in La Ronda for RMB 171 Million
June 3, 2025
Company
MSD Appoints Kyle Tattle as President of China Operations
May 30, 2025
Company
Drug
Zelgen’s Jaktinib Receives NMPA Approval for Myelofibrosis Treatment
May 30, 2025
Others
MSD and Daiichi Sankyo Withdraw US Filing for Patritumab Deruxtecan in EGFR-Mutated NSCLC
May 30, 2025
Company
Drug
Fosun Pharma’s FCN-159 and FCN-437c Win NMPA Marketing Approvals
May 30, 2025
Company
Deals
CSPC Pharmaceutical in Advanced Talks for $5B Licensing Deals
May 30, 2025
Company
Medical Device
Acotec Scientific’s E-Peridge Balloon Catheter Approved by China’s NMPA
May 30, 2025
Company
Drug
Jiangsu Hengrui Secures NMPA Approvals for Trastuzumab Rezetecan, Famitinib and HR20013
May 30, 2025
1
2
…
351
352
353
354
355
…
1,208
1,209
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?